To date, ML approaches for predicting mortality risk and prognosis in patients with anti-MDA5+DM-ILD have been infrequent, and there remains a lack of a concise, practical tool for directly calculating mortality risk in these patients. The gene discussed is IFIH1; the disease is interstitial lung disease.